Associated Papers
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
Torres-Ayuso P et al.
Npj Genomic Medicine, 2018
29951225 (PubMed )
Supplement: 41525_2018_55_MOESM2_ESM.xls › Sup_File_1
Concurrent mutations in six amino acids in beta-glucuronidase improve its thermostability.
Xiong AS et al.
Protein Engineering, Design & Selection : Peds, 2007
Select a paper to view details